Onsdag 28 Oktober | 21:10:43 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Clavister - Covid-19 Related Delays Hurts Revenue

2020-09-11 08:10:00

Redeye lowers its valuation of Clavister following weaker than expected Q2 revenue figures. We cut our short-term revenue forecasts, which are partly mitigated by positive cost adjustments, as cost and cash management exceeded expectations for the second consecutive quarter. Recognised revenue disappointments were offset by strong order intake and billings, which should support growth in the coming quarters.

Read more and download the Research Update

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/